Work

Decreased astrocytic CCL5 by Mir324 ameliorates ischemic stroke injury via the CCR5/ERK/CREB pathway

Year: 2026
Type: preprint
Abstract: Following ischemic stroke, Ccl5 mRNA expression increased, while Mir324 expression decreased in the peri-infarct cortex of middle cerebral artery occlusion (MCAO) mice. However, the roles of CCL5 and Mir324 in stroke remained largely unclear. Here, we show that inhibiting CCL5 using antibodies or Mir324 not only reduced infarct area and preserved neurological function in MCAO mice but also attenuated astrocyte reactivity and microglial activation, protected dendritic structures, and maintained spine density. In an astrocyte-neuron co-culture system after oxygen-glucose deprivation (OGD), inhibiting astrocytic CCL5 by antibody or Mir324 decreased neuronal apoptosis and preserved dendritic structure. Importantly, the suppression of CCL5 enhanced ERK/CREB pathway signaling both in vivo and in vitro. Consistent with these findings, the application of Maraviroc, a CCR5 antagonist, reduced infarct size, decreased neuronal apoptosis, and upregulated the ERK/CREB pathway in neurons treated with OGD. In conclusion, targeting the CCL5 pathway via Mir324 represents a promising therapeutic strategy for alleviating ischemic stroke damage through modulation of the neuronal CCR5/ERK/CREB pathway.
Source: eLife
Language: English
Subfield: Neurology
Open Access status: gold
Estimated APC paid: $2,500
OpenAlex ID: W4402683609
Cites: 81
Cited by:
Related to: 10